<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE335nnn/GSE335175/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE335175</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Genomic hallmarks of depot medroxyprogesterone acetate-associated meningiomas [RNA-seq]</name><description>Integrated genomic characterization of meningiomas from 10 women with long-term exposure to depot medroxyprogesterone acetate (DMPA), a commonly used injectable progestin contraceptive. All tumors were newly diagnosed WHO grade 1 meningiomas. We profiled genome-wide DNA methylation (Illumina Infinium MethylationEPIC v2.0) and performed bulk RNA sequencing on all 10 tumors, and integrated these data with public reference meningioma cohorts (Baylor, GSE189521; Heidelberg, GSE109381) for methylation classifier assignment, consensus clustering, copy-number analysis, and differential methylation testing.</description><dates><publication>2026/06/12</publication></dates><accession>GSE335175</accession><cross_references><GSM>GSM9807640</GSM><GSM>GSM9807642</GSM><GSM>GSM9807641</GSM><GSM>GSM9807644</GSM><GSM>GSM9807643</GSM><GSM>GSM9807646</GSM><GSM>GSM9807645</GSM><GSM>GSM9807648</GSM><GSM>GSM9807647</GSM><GSM>GSM9807639</GSM><GPL>30173</GPL><GSE>335175</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>